Comment on What's the Most Important Drug in Regeneron Pharmaceuticals' Pipeline?

What's the Most Important Drug in Regeneron Pharmaceuticals' Pipeline?

Regeneron Pharmaceuticals (NASDAQ: REGN) has four significant medications on the market, including three that have won Food and Drug Administration approval since 2015, and it's investing big money in research and development to provide it with a steady stream of new products. One of the most important drugs in its research pipeline is REGN-2810, a cancer-fighting drug that inhibits PD-1 so that cancer can't hide from the immune system.In this clip from the Motley Fool's Industry Focus: Healthcare podcast, analyst Kristine Harjes is joined by Todd Campbell to discuss Regeneron Pharmaceuticals' R&D efforts, including REGN-2810's development.A full transcript follows the video.Continue reading

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News